APO Research
Talk to an analyst

APO RESEARCH · REPORT

Charcot-Marie-Tooth Disease Type I A Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Charcot-Marie-Tooth Disease Type I A Drug Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchCharcot-Marie-Tooth Disease Type I A Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Charcot-Marie-Tooth Disease Type I A Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Charcot-Marie-Tooth Disease Type I A Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Charcot-Marie-Tooth Disease Type I A Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Charcot-Marie-Tooth Disease Type I A Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Charcot-Marie-Tooth Disease Type I A Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Charcot-Marie-Tooth Disease Type I A Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Charcot-Marie-Tooth Disease Type I A Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Charcot-Marie-Tooth Disease Type I A Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Charcot-Marie-Tooth Disease Type I A Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Charcot-Marie-Tooth Disease Type I A Drug include Pharnext SA, Lead Discovery Center GmbH, Genzyme Corp, Affectis Pharmaceuticals AG and Addex Therapeutics Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Charcot-Marie-Tooth Disease Type I A Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Charcot-Marie-Tooth Disease Type I A Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Charcot-Marie-Tooth Disease Type I A Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Charcot-Marie-Tooth Disease Type I A Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Charcot-Marie-Tooth Disease Type I A Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Charcot-Marie-Tooth Disease Type I A Drug sales, projected growth trends, production technology, application and end-user industry.

Charcot-Marie-Tooth Disease Type I A Drug Segment by Company

Pharnext SA

Lead Discovery Center GmbH

Genzyme Corp

Affectis Pharmaceuticals AG

Addex Therapeutics Ltd

Charcot-Marie-Tooth Disease Type I A Drug Segment by Type

ADX-71441

AFC-5128

Others

Charcot-Marie-Tooth Disease Type I A Drug Segment by Application

Hospital

Clinic

Others

Charcot-Marie-Tooth Disease Type I A Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Charcot-Marie-Tooth Disease Type I A Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Charcot-Marie-Tooth Disease Type I A Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Charcot-Marie-Tooth Disease Type I A Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Charcot-Marie-Tooth Disease Type I A Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Charcot-Marie-Tooth Disease Type I A Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Charcot-Marie-Tooth Disease Type I A Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ADX-71441 Major Manufacturers Table 3. AFC-5128 Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Others Major Manufacturers Table 9. Charcot-Marie-Tooth Disease Type I A Drug Industry Trends Table 10. Charcot-Marie-Tooth Disease Type I A Drug Industry Drivers Table 11. Charcot-Marie-Tooth Disease Type I A Drug Industry Opportunities and Challenges Table 12. Charcot-Marie-Tooth Disease Type I A Drug Industry Restraints Table 13. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region (2021-2026) Table 17. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region (2027-2032) Table 18. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region (2021-2026) & (K Units) Table 20. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region (2027-2032) & (K Units) Table 21. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Region (2021-2026) Table 22. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Region (2027-2032) Table 23. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Charcot-Marie-Tooth Disease Type I A Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Charcot-Marie-Tooth Disease Type I A Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers, Product Type & Application Table 31. Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Charcot-Marie-Tooth Disease Type I A Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2021-2026) Table 38. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2027-2032) Table 39. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2026) & (K Units) Table 41. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2027-2032) & (K Units) Table 42. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2021-2026) Table 43. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2027-2032) Table 44. Global Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2021-2026) Table 50. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2027-2032) Table 51. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2027-2032) & (K Units) Table 54. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2021-2026) Table 55. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2027-2032) Table 56. Global Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Pharnext SA Company Information Table 59. Pharnext SA Business Overview Table 60. Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 62. Pharnext SA Recent Development Table 63. Lead Discovery Center GmbH Company Information Table 64. Lead Discovery Center GmbH Business Overview Table 65. Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 67. Lead Discovery Center GmbH Recent Development Table 68. Genzyme Corp Company Information Table 69. Genzyme Corp Business Overview Table 70. Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 72. Genzyme Corp Recent Development Table 73. Affectis Pharmaceuticals AG Company Information Table 74. Affectis Pharmaceuticals AG Business Overview Table 75. Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 77. Affectis Pharmaceuticals AG Recent Development Table 78. Addex Therapeutics Ltd Company Information Table 79. Addex Therapeutics Ltd Business Overview Table 80. Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio Table 82. Addex Therapeutics Ltd Recent Development Table 83. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2026) & (K Units) Table 86. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2027-2032) & (K Units) Table 87. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 88. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 89. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2026) & (K Units) Table 92. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2027-2032) & (K Units) Table 93. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 94. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 95. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 99. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 100. North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 101. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 102. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 103. United States Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 104. Canada Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 105. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2026) & (K Units) Table 108. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2027-2032) & (K Units) Table 109. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 110. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 111. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2026) & (K Units) Table 114. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2027-2032) & (K Units) Table 115. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 116. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 117. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 121. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 122. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 123. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 124. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 125. Germany Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 126. France Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 127. U.K. Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 128. Italy Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 129. Netherlands Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 130. China Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2026) & (US$ Million) Table 131. China Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2027-2032) & (US$ Million) Table 132. China Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2026) & (K Units) Table 133. China Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2027-2032) & (K Units) Table 134. China Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 135. China Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 136. China Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2026) & (US$ Million) Table 137. China Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2027-2032) & (US$ Million) Table 138. China Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2026) & (K Units) Table 139. China Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2027-2032) & (K Units) Table 140. China Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 141. China Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2026) & (K Units) Table 145. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2027-2032) & (K Units) Table 146. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 147. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 148. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2026) & (K Units) Table 151. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2027-2032) & (K Units) Table 152. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 153. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 159. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 160. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 161. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 162. Japan Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 163. South Korea Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 164. India Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 165. Australia Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 166. China Taiwan Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2026) & (K Units) Table 171. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2027-2032) & (K Units) Table 172. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 173. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 174. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2026) & (K Units) Table 177. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2027-2032) & (K Units) Table 178. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 179. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 180. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2026) & (K Units) Table 185. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2027-2032) & (K Units) Table 186. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 187. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Brazil Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 189. Argentina Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 190. Chile Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 191. Colombia Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 192. Peru Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 194. Israel Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 195. UAE Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 196. Turkey Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 197. Iran Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 198. Egypt Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Charcot-Marie-Tooth Disease Type I A Drug Distributors List Table 202. Charcot-Marie-Tooth Disease Type I A Drug Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Charcot-Marie-Tooth Disease Type I A Drug Image Figure 2. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. ADX-71441 Image Figure 5. AFC-5128 Image Figure 6. Others Image Figure 7. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Charcot-Marie-Tooth Disease Type I A Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Others Image Figure 12. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Charcot-Marie-Tooth Disease Type I A Drug Sales (2021-2032) & (K Units) Figure 18. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Charcot-Marie-Tooth Disease Type I A Drug Sales YoY (2021-2032) & (K Units) Figure 21. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales YoY (2021-2032) & (K Units) Figure 22. China Charcot-Marie-Tooth Disease Type I A Drug Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Charcot-Marie-Tooth Disease Type I A Drug Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales YoY (2021-2032) & (K Units) Figure 25. Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2021-2032) Figure 34. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2021-2032) Figure 40. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Type (2021-2032) Figure 41. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Type (2021-2032) Figure 42. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Application (2021-2032) Figure 43. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Application (2021-2032) Figure 44. North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country (2021-2032) Figure 45. North America Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Country (2021-2032) Figure 46. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Type (2021-2032) Figure 47. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Type (2021-2032) Figure 48. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Application (2021-2032) Figure 49. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Application (2021-2032) Figure 50. Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country (2021-2032) Figure 51. Europe Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Country (2021-2032) Figure 52. China Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Type (2021-2032) Figure 53. China Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Type (2021-2032) Figure 54. China Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Application (2021-2032) Figure 55. China Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Application (2021-2032) Figure 56. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Type (2021-2032) Figure 57. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Type (2021-2032) Figure 58. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Application (2021-2032) Figure 59. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Application (2021-2032) Figure 60. Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country (2021-2032) Figure 61. Asia Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales Share by Country (2021-2032) Figure 68. Charcot-Marie-Tooth Disease Type I A Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Charcot-Marie-Tooth Disease Type I A Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • ADX-71441
  • AFC-5128
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Pharnext SA
  • Lead Discovery Center GmbH
  • Genzyme Corp
  • Affectis Pharmaceuticals AG
  • Addex Therapeutics Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Charcot-Marie-Tooth Disease Type I A Drug Market by Type
  3. 1.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ADX-71441
  5. 1.2.3 AFC-5128
  6. 1.2.4 Others
  7. 1.3 Charcot-Marie-Tooth Disease Type I A Drug Market by Application
  8. 1.3.1 Global Charcot-Marie-Tooth Disease Type I A Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Charcot-Marie-Tooth Disease Type I A Drug Market Dynamics
  1. 2.1 Charcot-Marie-Tooth Disease Type I A Drug Industry Trends
  2. 2.2 Charcot-Marie-Tooth Disease Type I A Drug Industry Drivers
  3. 2.3 Charcot-Marie-Tooth Disease Type I A Drug Industry Opportunities and Challenges
  4. 2.4 Charcot-Marie-Tooth Disease Type I A Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region
  3. 3.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region
  9. 3.4.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Manufacturers
  2. 4.1.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Manufacturers
  6. 4.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Charcot-Marie-Tooth Disease Type I A Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Charcot-Marie-Tooth Disease Type I A Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers, Product Type & Application
  13. 4.7 Global Charcot-Marie-Tooth Disease Type I A Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Charcot-Marie-Tooth Disease Type I A Drug Market CR5 and HHI
  16. 4.8.2 2025 Charcot-Marie-Tooth Disease Type I A Drug Tier 1, Tier 2, and Tier 3
5 Charcot-Marie-Tooth Disease Type I A Drug Market by Type
  1. 5.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type
  2. 5.1.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type
  6. 5.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Charcot-Marie-Tooth Disease Type I A Drug Price by Type
6 Charcot-Marie-Tooth Disease Type I A Drug Market by Application
  1. 6.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application
  2. 6.1.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application
  6. 6.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Charcot-Marie-Tooth Disease Type I A Drug Price by Application
7 Company Profiles
  1. 7.1 Pharnext SA
  2. 7.1.1 Pharnext SA Company Information
  3. 7.1.2 Pharnext SA Business Overview
  4. 7.1.3 Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  6. 7.1.5 Pharnext SA Recent Developments
  7. 7.2 Lead Discovery Center GmbH
  8. 7.2.1 Lead Discovery Center GmbH Company Information
  9. 7.2.2 Lead Discovery Center GmbH Business Overview
  10. 7.2.3 Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  12. 7.2.5 Lead Discovery Center GmbH Recent Developments
  13. 7.3 Genzyme Corp
  14. 7.3.1 Genzyme Corp Company Information
  15. 7.3.2 Genzyme Corp Business Overview
  16. 7.3.3 Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  18. 7.3.5 Genzyme Corp Recent Developments
  19. 7.4 Affectis Pharmaceuticals AG
  20. 7.4.1 Affectis Pharmaceuticals AG Company Information
  21. 7.4.2 Affectis Pharmaceuticals AG Business Overview
  22. 7.4.3 Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  24. 7.4.5 Affectis Pharmaceuticals AG Recent Developments
  25. 7.5 Addex Therapeutics Ltd
  26. 7.5.1 Addex Therapeutics Ltd Company Information
  27. 7.5.2 Addex Therapeutics Ltd Business Overview
  28. 7.5.3 Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
  30. 7.5.5 Addex Therapeutics Ltd Recent Developments
8 North America
  1. 8.1 North America Charcot-Marie-Tooth Disease Type I A Drug Market Size by Type
  2. 8.1.1 North America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2021-2032)
  5. 8.2 North America Charcot-Marie-Tooth Disease Type I A Drug Market Size by Application
  6. 8.2.1 North America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2021-2032)
  9. 8.3 North America Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country
  10. 8.3.1 North America Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Charcot-Marie-Tooth Disease Type I A Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Charcot-Marie-Tooth Disease Type I A Drug Market Size by Type
  2. 9.1.1 Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2021-2032)
  5. 9.2 Europe Charcot-Marie-Tooth Disease Type I A Drug Market Size by Application
  6. 9.2.1 Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2021-2032)
  9. 9.3 Europe Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country
  10. 9.3.1 Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Charcot-Marie-Tooth Disease Type I A Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Charcot-Marie-Tooth Disease Type I A Drug Market Size by Type
  2. 10.1.1 China Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032)
  4. 10.1.3 China Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2021-2032)
  5. 10.2 China Charcot-Marie-Tooth Disease Type I A Drug Market Size by Application
  6. 10.2.1 China Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032)
  8. 10.2.3 China Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Charcot-Marie-Tooth Disease Type I A Drug Market Size by Type
  2. 11.1.1 Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2021-2032)
  5. 11.2 Asia Charcot-Marie-Tooth Disease Type I A Drug Market Size by Application
  6. 11.2.1 Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2021-2032)
  9. 11.3 Asia Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country
  10. 11.3.1 Asia Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Charcot-Marie-Tooth Disease Type I A Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Market Size by Type
  2. 12.1.1 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Market Size by Application
  6. 12.2.1 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country
  10. 12.3.1 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Charcot-Marie-Tooth Disease Type I A Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Charcot-Marie-Tooth Disease Type I A Drug Value Chain Analysis
  2. 13.1.1 Charcot-Marie-Tooth Disease Type I A Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Charcot-Marie-Tooth Disease Type I A Drug Production Mode & Process
  6. 13.2 Charcot-Marie-Tooth Disease Type I A Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Charcot-Marie-Tooth Disease Type I A Drug Distributors
  9. 13.2.3 Charcot-Marie-Tooth Disease Type I A Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst